Indication
Uveitis
Uveitis is a heterogeneous group of intraocular inflammatory diseases affecting the uveal tract—consisting of the iris, ciliary body, and choroid—as well as adjacent ocular structures such as the retina, optic nerve, and vitreous humor. Read more about Uveitis
218 drugs 128 manufacturers
Drugs that treat it
Common Uveitis therapies.
PREDNISONE
PREDNISONE
DEXAMETHASONE
DEXAMETHASONE SOD PHOS-WATER (dexamethasone sodium phosphate/PF)
PREDNISONE
DEXAMETHASONE
DEXAMETHASONE SODIUM PHOSPHATE
DEXAMETHASONE SODIUM PHOSPHATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonUveitis is a heterogeneous group of intraocular inflammatory diseases affecting the uveal tract—consisting of the iris, ciliary body, and choroid—as well as adjacent ocular structures such as the retina, optic nerve, and vitreous humor.
It predominantly affects working-age adults and can arise from infectious etiologies, systemic autoimmune or autoinflammatory disorders, ocular trauma, or idiopathic mechanisms.
Pathophysiologically classified as anterior, intermediate, posterior, or panuveitis based on the primary anatomical site of inflammation, it is characterized by cellular infiltration, vascular permeability, and tissue damage.
Clinical manifestations commonly include eye pain, conjunctival injection, photophobia, blurred vision, and floaters, with severe or chronic inflammation carrying a substantial risk of vision impairment, macular edema, glaucoma, and cataracts.
- nih.gov
Uveitis is a heterogeneous group of intraocular inflammatory diseases affecting the uveal tract—consisting of the iris, ciliary body, and choroid—as well as adjacent ocular structures such as the retina, optic nerve, and vitreous humor Pathophysiologically classified as anterior, intermediate, posterior, or panuveitis based on the primary anatomical site of inflammation, it is characterized by cellular infiltration, vascular permeability, and tissue damage
- nih.gov
Uveitis is a heterogeneous group of intraocular inflammatory diseases affecting the uveal tract—consisting of the iris, ciliary body, and choroid—as well as adjacent ocular structures such as the retina, optic nerve, and vitreous humor Pathophysiologically classified as anterior, intermediate, posterior, or panuveitis based on the primary anatomical site of inflammation, it is characterized by cellular infiltration, vascular permeability, and tissue damage Clinical manifestations commonly includ...
- nih.gov
Uveitis is a heterogeneous group of intraocular inflammatory diseases affecting the uveal tract—consisting of the iris, ciliary body, and choroid—as well as adjacent ocular structures such as the retina, optic nerve, and vitreous humor
- nih.gov
It predominantly affects working-age adults and can arise from infectious etiologies, systemic autoimmune or autoinflammatory disorders, ocular trauma, or idiopathic mechanisms
- nih.gov
It predominantly affects working-age adults and can arise from infectious etiologies, systemic autoimmune or autoinflammatory disorders, ocular trauma, or idiopathic mechanisms Clinical manifestations commonly include eye pain, conjunctival injection, photophobia, blurred vision, and floaters, with severe or chronic inflammation carrying a substantial risk of vision impairment, macular edema, glaucoma, and cataracts
Personalize your experience
Follow Uveitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.